
News|Articles|January 1, 2006
Pipeline Preview
Methylphenidate transdermal patch (Daytrana, Shire/Noven) to treat attention-deficit/hyperactivity disorder (ADHD)
Advertisement
Recommendations for approval
Approvable designations
Fast-track designation
Priority review
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
Cancer survival fell and deaths rose during first two years of COVID-19
3
PBM reform. It has finally happened
4
TrumpRx launches; some experts question its long-term value
5

























